Bristol Myers Squibb (BMY)

R&D Expense Growth

11.70%

Quarterly · Period ending:

BMY logo

BMY R&D Expense Growth

Latest reported11.70%
BMY Quarterly R&D Growth (QoQ) (0.00% → 11.70%)
High-resolution chart · PNG

BMY r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-2.5591%
-9.9291%
17.7453%
1.4831%
5.8296%
-13.3981%
19.4896%
-4.8565%
7.0922%
2.6699%
3.5176%
3.6458%
0.2611%
-2.2959%
13.2948%
7.7882%
-1.5337%
-0.6098%
-2.381%
8.7379%
2.3179%
-6.5015%
10.2389%
-0.3401%
1.3793%
-3.9735%
10.219%
1.107%
3.8314%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.